Cingulate CING
NASDAQ CING
$5.26 +0.03 (+0.48%)
As of: Sep 22, 2026 · 11:16 AM EDT

Cingulate (CING) Accumulated Expenses (2021 - 2026)

Cingulate's (CING) quarterly Accumulated Expenses came in at $1.3 million in Q2 2026, up 163.57% on a YoY basis from $501786.0 in Q2 2025, and down 24.08% quarter-over-quarter from $1.7 million in Q4 2025.

Analysis

Cingulate (CING) Accumulated Expenses (2021 - 2026) Analysis & Trends

Cingulate (CING) has reported Accumulated Expenses for 6 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accumulated Expenses rose 163.57% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2026 stood at $1.3 million (up 163.57% YoY), and the FY2025 full-year result was $1.7 million, up 67.57% from the prior year.
  • Accumulated Expenses fell to $1.3 million in Q2 2026 per CING's latest filing, from $1.7 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.7 million in Q4 2025 and bottomed at $311573.0 in Q2 2022.
  • Historically, Accumulated Expenses has averaged $906178.3 across 5 years, with a median of $756035.0 in 2022.
  • The sharpest annual moves came in 2024 and 2025: Accumulated Expenses plunged 62.36% in 2024, then soared 297.9% in 2025.
  • Over 5 years, Accumulated Expenses stood at $894635.0 in 2022, then jumped by 84.6% to $1.7 million in 2023, then plunged by 37.05% to $1.0 million in 2024, then jumped by 67.57% to $1.7 million in 2025, then declined by 24.08% to $1.3 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $1.3 million, $1.7 million, and $1.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Cingulate 72.81 Mn 72.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.32 Mn
Dec 31, 2025 1.74 Mn
Sep 30, 2025 1.60 Mn
Jun 30, 2025 501,786.00
Mar 31, 2025 601,840.00
Dec 31, 2024 1.04 Mn
Sep 30, 2024 402,152.00
Jun 30, 2024 383,313.00
Mar 31, 2024 1.12 Mn
Dec 31, 2023 1.65 Mn
Sep 30, 2023 692,008.00
Jun 30, 2023 1.02 Mn
Mar 31, 2023 699,182.00
Dec 31, 2022 894,635.00
Sep 30, 2022 670,651.00
Jun 30, 2022 311,573.00
Mar 31, 2022 756,035.00
Dec 31, 2021 601,300.00
API Access

Cingulate Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CING&period=max&api_key=YOUR_API_KEY